Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for patients with primary liver cancer undergoing transarterial chemoembolization

Table 2 Baseline disease-related features of participants, n (%)

Parameters	Good prognosis group (n = 88)	Poor prognosis group (n = 74)	W/χ2	P value
Tumor diameter (cm)	4.2 (3, 7)	5.2 (3.12, 10)	2629.500	0.035
Number of tumors	19 (21.59)	27 (36.49)	4.387	0.036
Tumor thrombus	58 (65.91)	44 (59.46)	0.717	0.397
Vascular invasion	49 (55.68)	47 (63.51)	1.021	0.312
Child-Pugh grade (A/BC)	60 (68.18)/28 (31.82)	52 (70.27)/22 (29.73)	0.082	0.774
BCLC grade (A/≥ B)	42 (47.73)/46 (52.27)	37 (50)/37 (50)	0.083	0.773
Ascites	41 (46.59)	42 (56.76)	1.663	0.197
Portal hypertension	52 (59.09)	46 (62.16)	0.159	0.690
Portal vein thrombosis	45 (51.14)	52 (70.27)	6.126	0.013
Length of hospital stay (days)	7 (5, 14)	7.5 (2, 15)	3779.500	0.078
Duration of surgery (minutes)	85 (80, 110)	80 (70, 88)	3948.000	0.019

BCLC: Barcelona Clinic Liver Cancer.